Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 143.00 | |
25 mg | In stock | $ 241.00 | |
50 mg | In stock | $ 365.00 | |
100 mg | In stock | $ 559.00 |
Description | LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1]. |
Molecular Weight | 327.31 |
Formula | C16H14FN5O2 |
CAS No. | 1627696-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/mL(198.59 mM)
Ethanol: 32 mg/mL(97.77mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY3143921 hydrate 1627696-53-0 Cell Cycle/Checkpoint CDK LY3143921 Hydrate LY-3143921 hydrate LY 3143921 Hydrate LY-3143921 Hydrate inhibitor inhibit